EquityPanditβs Outlook for Lupin for the week Β (AprilΒ 03, 2017 βΒ AprilΒ 07, 2017) : LUPIN: Lupin closed the week on negative note losing around 2.90%....
Lupin has got the US health regulator’s approval for marketing a generic version of Novartis’ inhalation product Tobi that is used in treating cystic fibrosis...